ADVAIR HFA (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the ADVAIR HFA drug offered from GlaxoSmithKline LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | fluticasone propionate and salmeterol xinafoate |
SUBSTANCE NAME: | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | AEROSOL, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-09-29 |
END MARKETING DATE: | 0000-00-00 |
ADVAIR HFA HUMAN PRESCRIPTION DRUG Details:
Item Description | ADVAIR HFA from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 45; 21(ug/1; ug/1) |
START MARKETING DATE: | 2008-09-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0715_a30cf43f-52d4-4f4f-a325-eca8e7fc1425 |
PRODUCT NDC: | 0173-0715 |
APPLICATION NUMBER: | NDA021254 |
Other FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers: